4//SEC Filing
Gabay Avraham 4
Accession 0001213900-26-000658
CIK 0001176309other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 8:00 PM ET
Size
9.4 KB
Accession
0001213900-26-000658
Insider Transaction Report
Form 4
Gabay Avraham
Chief Financial Officer
Transactions
- Award
Common Stock
2025-12-31+81,216→ 515,256 total - Award
Common Stock
2025-12-31+115,000→ 630,256 total - Award
Performance Stock Units
2025-12-31+19,000→ 19,000 total→ Common Stock (19,000 underlying)
Footnotes (3)
- [F1]Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.
- [F2]Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.
- [F3]Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001777328
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 8:00 PM ET
- Size
- 9.4 KB